|Articles|August 1, 2003

Infants' rapid weight gain risks adult obesity

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related to this article

Ecnoglutide shows favorable safety, BMI reduction in adolescents with obesity in phase 1b trial | Image Credit: © CoetzeeRising/peopleimages.com - stock.adobe.com

September 30th, 2026

Ecnoglutide shows favorable safety, BMI reduction in adolescents with obesity in phase 1b trial

In a 48-patient phase 1b trial, ecnoglutide was well tolerated in adolescents with obesity and reduced BMI up to 12.6% at 20 weeks.

Trending on Contemporary Pediatrics

FAQ: How should pediatricians manage UTIs under new AAP guidance?

Recognizing skin conditions in children with darker skin tones

Global measles cases in children under 5 up 40% since COVID-19

Family-focused behavioral care tied to better HbA1c in pediatric T1D

FDA proposes cadmium action levels for baby food under Closer to Zero